ArticleInternal medicine (Tokyo, Japan)2024

High Efficacy and Safety of Asciminib in a Chronic Myeloid Leukemia Patient with Chronic Kidney Disease Following Renal Transplantation.

Yasuhiro Uchida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.